Epalrestat

Information about Epalrestat

Epalrestat uses

Epalrestat is used in the treatment of diabetic nerve pain.

How epalrestat works

Epalrestat is an aldose reductase inhibitor. It blocks the accumulation of sorbitol in cells, which has been related to causing diabetic nerve disease.

Common side effects of epalrestat

Nausea, Vomiting, Abnormal liver function

Available Medicine for Epalrestat

  • ₹182 to ₹310
    Zydus Cadila
    2 variant(s)
  • ₹96 to ₹170
    Macleods Pharmaceuticals Pvt Ltd
    2 variant(s)
  • ₹64
    Micro Labs Ltd
    1 variant(s)
  • ₹148 to ₹199
    Kineses Laboratories
    3 variant(s)
  • ₹41
    Macleods Pharmaceuticals Pvt Ltd
    1 variant(s)
  • ₹65
    Sun Pharmaceutical Industries Ltd
    1 variant(s)
  • ₹236
    Shilpex Pharmysis
    1 variant(s)
  • ₹95
    Walton Healthcare Pvt. Ltd
    1 variant(s)
  • ₹109 to ₹262
    Druto Laboratories
    2 variant(s)
  • ₹183
    Globus Labs
    1 variant(s)

Expert advice for Epalrestat

  • Adherence to antidiabetic therapy can delay the onset of or prevent diabetic nerve disease.
  • If you have existing diabetic nerve disease, wear proper footwear and examine your feet every day to detect lesions early.
  • If you have a foot injury or open wound, avoid engaging in weight-bearing activities.


Content on this page was last updated on 18 February, 2020, by Dr. Varun Gupta (MD Pharmacology)